« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 4
, Pages
348-355
, April 2009
Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD
To access this article, please choose from the options below
Funding: The COPD Foundation and National Institutes of Health HL077612 and HL075476.
Conflict of Interest: R. Graham Barr, MD, DrPH: none. Bartolome R. Celli, MD: research grants from Glaxo Smith Kline (GSK), Boehringer Ingelheim (BI), Forrest Medical, Astra Zeneca; advisory board payments from GSK, BI, Almirall, Astra Zeneca; speakers' fees from GSK, BI, Astra Zeneca, Almirall. David Mannino, MD: research funding from GSK, Pfizer, and Novartis; consultant or speakers' fees from GSK, Pfizer, BI, Astra-Zeneca, Dey, and Sepracor. Thomas Petty, MD: none. Stephen I. Rennard, MD: research grants from Almirall, Lorillard, Centocor, Novartis, GSK, Philip Morris, Institute for Science and Health, Roche; consultancy and advisory board payments from Abbott, Johnson & Johnson, Almirall, Novartis, Altana, Roche, Anthera, Quintiles, GSK, Targegen; speakers' fees from Adams, Novartis, AstraZeneca, Pfizer. Frank C. Sciurba, MD: consultancy for Astra Zeneca, BI, Dey, GSK, Novartis, Pfizer, PneumRX, Respironics, Schering and Sepracor. James K. Stoller, MD, MS: consultancy for Talecris Biotherapeutics, BI; speaker for Grifols, Baxter, CSL-Behring, Pfizer, Talecris. Byron M. Thomashow, MD: speakers' fees and consultancy for BI, Pfizer and GSK. Gerard M. Turino, MD: research grant from BI; consultancy for Talecris Corporation.
Authorship: All authors had access to the data and played a role in writing this manuscript.
PII: S0002-9343(08)01072-3
doi: 10.1016/j.amjmed.2008.09.042
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 4
, Pages
348-355
, April 2009

